Matt Buckley (@matttbuckley) 's Twitter Profile
Matt Buckley

@matttbuckley

Neuro, aging, therapeutics

Starting something new

Past - Cofounder @RetroBio_; PhD @BrunetLab

ID: 1146277583270633474

linkhttp://matthewtbuckley.com calendar_today03-07-2019 04:40:47

688 Tweet

1,1K Followers

828 Following

Karl Pfleger (@karlpfleger) 's Twitter Profile Photo

A 2nd important recent longevity development that is too-little discussed in the field: The first 2 FDA approved allogeneic stem cell therapies, both in past 2 years. - off-the-shelf - mass-producible - likely relevant for multiple age-related pathologies This is important!

A 2nd important recent longevity development that is too-little discussed in the field: The first 2 FDA approved allogeneic stem cell therapies, both in past 2 years.

- off-the-shelf
- mass-producible
- likely relevant for multiple age-related pathologies

This is important!
Matt Buckley (@matttbuckley) 's Twitter Profile Photo

another beautiful glimmer of progress using stem cell-derived cells in the central nervous system with transient immunosuppression to dramatically, durably improve life

Yishan (@yishan) 's Twitter Profile Photo

Here's what you do: First define the minimum amount of time to build a unit of industrial capacity as the time it takes to move the atoms. (This is similar to Elon's "idiot index" - how long does it take to move the physical components into the configuration for a factory, not

Fred Ehrsam (@fehrsam) 's Twitter Profile Photo

We believe improving the human experience is the most important thing to work on. This should be the goal of technology. And building technologies to interface with the brain is the most direct way of doing so.

Matt Buckley (@matttbuckley) 's Twitter Profile Photo

Colossal's PR game is absolutely fire. How many edits did they make based on ancient DNA? Dire wolves diverged >5M years ago and have >10M genetic changes from modern wolves. Vast majority of changes don't matter much. Power law. Does 1 edit convert a modern wolf into a

Jing Liang 🇺🇦 (@applehelix) 's Twitter Profile Photo

3/ Reduce GMP requirements for Ph 1 and GLP Tox req to be more in line with Australia. The gold plated approach is to make $5-10m GMP CMC investments for your GLP Tox and Ph 1. This is the biggest obstacle to capital efficiency at early stage.

Eyo (@eyolab) 's Twitter Profile Photo

In 2006, following the identification of microglial chemotaxis to injured sites mediated by ATP , Haynes et al. (nature.com/articles/nn180…), showed that P2RY12 ATP receptors facilitate this microglial chemotactic response🤩 #20YearsInVivoMGImaging

Matt Buckley (@matttbuckley) 's Twitter Profile Photo

prolonging human cognition will involve a combo of (1) cell therapy (2) brain machine interfaces (3) progressive replacement all have traction and are worth vigorously pursuing great thread by Sierra Lore